D03.8 Billable / specific Melanoma in situ of other sites
ICD-10-CM D03.8 identifies “Melanoma in situ of other sites” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 2: Neoplasms
Code-level instructions
Inclusion terms1
Melanoma in situ of scrotum
Excludes 11
carcinoma in situ of scrotum (D07.61)
Inherited instructions
Chapters 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
D00-D09 · In situ neoplasms (D00-D09)
Includes4
- Bowen's disease
- erythroplasia
- grade III intraepithelial neoplasia
- Queyrat's erythroplasia
Official index references
Official index references (18)
Melanoma(malignant) (18)
- Melanoma(malignant) › in situ › choroidDisease index
- Melanoma(malignant) › in situ › conjunctivaDisease index
- Melanoma(malignant) › in situ › eyeDisease index
- Melanoma(malignant) › in situ › female genital organ(external) NECDisease index
- Melanoma(malignant) › in situ › foreskinDisease index
- Melanoma(malignant) › in situ › irisDisease index
- Melanoma(malignant) › in situ › labium(majus) (minus)Disease index
- Melanoma(malignant) › in situ › lacrimal glandDisease index
- Melanoma(malignant) › in situ › male genital organ(external) NECDisease index
- Melanoma(malignant) › in situ › orbitDisease index
- Melanoma(malignant) › in situ › penisDisease index
- Melanoma(malignant) › in situ › prepuceDisease index
- Melanoma(malignant) › in situ › pudendumDisease index
- Melanoma(malignant) › in situ › retinaDisease index
- Melanoma(malignant) › in situ › retrobulbarDisease index
- Melanoma(malignant) › in situ › scrotumDisease index
- Melanoma(malignant) › in situ › specified site NECDisease index
- Melanoma(malignant) › in situ › vulvaDisease index
History
Code history
No recorded change since first observation
ChangedUnchanged
FY2016
Effective from
- First observed
Melanoma in situ of other sites
Billable diagnosis code
CDC/NCHS · FY2016All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Historical ICD-9 mappings · 2018
Historical mapping only; not an automatic code substitution.
- 172.8 · Approximate
This entry is a complete code in the selected edition. Reference checks do not establish clinical appropriateness or guarantee reimbursement.